Use, response and outcomes of second-line chemotherapy in patients with advanced biliary tract cancers.

Mathers, Brittney; Abadi, Shirin; Davies, Janine M; McIntyre, Connor; Ho, Cheryl

Mathers, Brittney; Abadi, Shirin; Davies, Janine M; McIntyre, Connor; Ho, Cheryl.

Affiliation

Mathers B; Department of Pharmacy, BC Cancer, Vancouver, Canada.
Abadi S; Department of Pharmacy, BC Cancer, Vancouver, Canada.
Davies JM; Department of Medical Oncology, BC Cancer, Vancouver, Canada.
McIntyre C; Department of Pharmacy, BC Cancer, Vancouver, Canada.
Ho C; Department of Medical Oncology, BC Cancer, Vancouver, Canada.

J Oncol Pharm Pract ; 29(6): 1381-1386, 2023 Sep.

Article in En | MEDLINE | ID: mdl-36320173

Subject(s)

Bile Duct Neoplasms; Biliary Tract Neoplasms; Humans; Capecitabine/therapeutic use; Biliary Tract Neoplasms/drug therapy; Biliary Tract Neoplasms/pathology; Retrospective Studies; Treatment Outcome; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Bile Duct Neoplasms/drug therapy; Fluorouracil/therapeutic use

Key words

Biliary tract cancer; chemotherapy; cholangiocarcinoma; gallbladder cancer; second line

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Duct Neoplasms / Biliary Tract Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2023 Document type: Article Affiliation country: Canada Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google